Patient Resource on Vascular Disorders: Understanding Hereditary Hemorrhagic Telangiectasia (HHT) - Top-Institutions - MDSpire

Patient Resource on Vascular Disorders: Understanding Hereditary Hemorrhagic Telangiectasia (HHT)

  • By

  • Rohan R Kasthuri

  • Harish Eswaran

  • Karen Smith

  • Raj S Kasthuri

  • February 3, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    University of Utah Health
    University of Utah Health

    Salt Lake City, UT

    Key Differentiators

    • Vascular Medicine
    • Genetics
    • Pulmonology

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Vascular Medicine
    • Genetics
    • Neurology

  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Vascular Medicine
    • Genetics
    • Interventional Radiology

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Genetics
    • Vascular Medicine
    • Pulmonology

Original Source(s)

Patient Resource on Vascular Disorders: Understanding Hereditary Hemorrhagic Telangiectasia (HHT)

  • by Rohan R Kasthuri, Harish Eswaran, Karen Smith, Raj S Kasthuri

  • February 3, 2026

Related Content

Momelotinib for myelofibrosis: our 14 years of experience with 100 clinical trial patients and recent FDA approval

Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial

Correction to: “The Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Type 2 Diabetes-A Real-World Study”

  • August 26, 2025